 |
| |||
| 21 CFR 11 dalis (A Food and Drug Administration (FDA) regulation, Title 21 of the Congressional Federal Record, Part 11. This regulation specifies the conditions and criteria for determining the validity and trustworthiness of electronic signatures and processes) | |||